Sign in
Explore the registryTrack Rapcabtagene autoleucel's trials

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

Rapcabtagene autoleucel (YTB323)OngoingActive not recruitingPhase 1Open NCT06617793 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…